Morgan Stanley’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285K Sell
58,229
-75,802
-57% -$413K ﹤0.01% 5718
2025
Q4
$757K Buy
134,031
+58,090
+76% +$313K ﹤0.01% 5317
2025
Q3
$387K Sell
75,941
-37,781
-33% -$218K ﹤0.01% 5616
2025
Q2
$575K Buy
113,722
+51,246
+82% +$264K ﹤0.01% 5402
2025
Q1
$353K Sell
62,476
-12,799
-17% -$105K ﹤0.01% 5488
2024
Q4
$653K Buy
75,275
+10,842
+17% +$64.1K ﹤0.01% 5309
2024
Q3
$447K Buy
64,433
+44,975
+231% +$279K ﹤0.01% 5457
2024
Q2
$121K Buy
+19,458
New +$146K ﹤0.01% 5897
2023
Q1
Sell
-92
Closed -$165 7724
2022
Q4
$165 Sell
92
-5,188
-98% -$10.3K ﹤0.01% 7658
2022
Q3
$17K Buy
5,280
+659
+14% +$2.23K ﹤0.01% 6851
2022
Q2
$15K Sell
4,621
-30
-0.6% -$120 ﹤0.01% 7091
2022
Q1
$24K Sell
4,651
-71
-2% -$353 ﹤0.01% 7068
2021
Q4
$36K Buy
+4,722
New +$45.8K ﹤0.01% 6961

Other funds holding CADL